Rab5A is associated with axillary lymph node metastasis in breast cancer patients

Cancer Science

Volumn 102, Issue 12, 2011, Pages 2172-2178

  Yang, Po Sheng ^a,b   Yin, Pen Hui ^c   Tseng, Ling Ming ^a,c   Yang, Chin Hua ^c   Hsu, Chih Yi ^c   Lee, Ming Yuan ^d   Horng, Cheng Fang ^d   Chi, Chin Wen ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d Sun Yat Sen Cancer Center   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; EPIDERMAL GROWTH FACTOR; PROTEIN RAB5A; RAB PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CELL MIGRATION; CONTROLLED STUDY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RAB5 GTP-BINDING PROTEINS;

EID: 81855217529     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02089.x     Document Type: Article

References (35)

1. Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997; 47: 28-51.
2. Fisher B, Bauer M, Wickerham DL et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983; 52: 1551-7.
3. Leong SP. Paradigm shift of staging and treatment for early breast cancer in the sentinel lymph node era. Breast J 2006; 12: S128-33.
4. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001; 2: 107-17.
5. Pfeffer S, Aivazian D. Targeting Rab GTPases to distinct membrane compartments. Nat Rev Mol Cell Biol 2004; 5: 886-96.
6. Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005; 65: 2516-9.
7. van der Bliek AM. A sixth sense for Rab5. Nat Cell Biol 2005; 7: 548-50.
8. Su X, Kong C, Stahl PD. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor. J Biol Chem 2007; 282: 21278-84.
9. Yu L, Hui-chen F, Chen Y et al. Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential. Clin Exp Metastasis 1999; 17: 213-9.
10. Li Y, Feng H, Chen Y. [RAB5A, a gene possibly related to metastasis of human carcinoma of the lung and stomach]. Zhonghua Zhong Liu Za Zhi 1999; 21: 178-81.
11. Fukui K, Tamura S, Wada A et al. Expression of Rab5a in hepatocellular carcinoma: Possible involvement in epidermal growth factor signaling. Hepatol Res 2007; 37: 957-65.
12. Zhao Z, Liu XF, Wu HC et al. Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway. Cancer Sci 2010; 101: 1454-62.
13. Barbieri MA, Roberts RL, Gumusboga A et al. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol 2000; 151: 539-50.
14. Barbieri MA, Fernandez-Pol S, Hunker C, Horazdovsky BH, Stahl PD. Role of rab5 in EGF receptor-mediated signal transduction. Eur J Cell Biol 2004; 83: 305-14.
15. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232.
16. Nieto Y, Nawaz F, Jones RB, Shpall EJ, Nawaz S. Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer. J Clin Oncol 2007; 25: 4405-13.
17. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007; 608: 1-22.
18. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
19. D'Eredita G, Giardina C, Martellotta M, Natale T, Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 2001; 37: 591-6.
20. Audhya A, Desai A, Oegema K. A role for Rab5 in structuring the endoplasmic reticulum. J Cell Biol 2007; 178: 43-56.
21. Voeltz GK, Rolls MM, Rapoport TA. Structural organization of the endoplasmic reticulum. EMBO Rep 2002; 3: 944-50.
22. Horazdovsky B. Endosomal protein traffic meets nuclear signal transduction head on. Dev Cell 2004; 6: 161-2.
23. Miaczynska M, Christoforidis S, Giner A et al. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 2004; 116: 445-56.
24. Wang SC, Hung MC. Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors. Clin Cancer Res 2009; 15: 6484-9.
25. Lo HW, Xia W, Wei Y, Ali-Seyed M, Huang SF, Hung MC. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 2005; 65: 338-48.
26. Eccles S, Paon L, Sleeman J. Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin Exp Metastasis 2007; 24: 619-36.
27. Roberts RL, Barbieri MA, Ullrich J, Stahl PD. Dynamics of rab5 activation in endocytosis and phagocytosis. J Leukoc Biol 2000; 68: 627-32.
28. Chamberlain MD, Berry TR, Pastor MC, Anderson DH. The p85alpha subunit of phosphatidylinositol 3′-kinase binds to and stimulates the GTPase activity of Rab proteins. J Biol Chem 2004; 279: 48607-14.
29. Martinu L, Santiago-Walker A, Qi H, Chou MM. Endocytosis of epidermal growth factor receptor regulated by Grb2-mediated recruitment of the Rab5 GTPase-activating protein RN-tre. J Biol Chem 2002; 277: 50996-1002.
30. Rae JM, Scheys JO, Clark KM, Chadwick RB, Kiefer MC, Lippman ME. EGFR and EGFRvIII expression in primary breast cancer and cell lines. Breast Cancer Res Treat 2004; 87: 87-95.
31. Kruger JS, Reddy KB. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 2003; 1: 801-9.
32. Palamidessi A, Frittoli E, Garre M et al. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell 2008; 134: 135-47.
33. Senft J, Helfer B, Frisch SM. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res 2007; 67: 11505-9.
34. Torres VA, Mielgo A, Barila D, Anderson DH, Stupack D. Caspase 8 promotes peripheral localization and activation of Rab5. J Biol Chem 2008; 283: 36280-9.
35. Pellinen T, Arjonen A, Vuoriluoto K, Kallio K, Fransen JA, Ivaska J. Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. J Cell Biol 2006; 173: 767-80.